The human polyomaviruses

Cellular and Molecular Life Sciences

Volumn 63, Issue 7-8, 2006, Pages 865-876

  Eash, S ^a   Manley, K ^b   Gasparovic, M ^b   Querbes, W ^a   Atwood, W J ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

BK virus (BKV); JC virus (JCV); Polyomavirus; Polyomavirus induced nephropathy (PVN); Progressive multifocal leukoencephalopathy (PML); Viral lifecycle

Indexed keywords

DNA; PROTEIN MAD1; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

CELLULAR DISTRIBUTION; CLINICAL FEATURE; DEMYELINATION; ENDOCYTOSIS; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; LIFE CYCLE; NONHUMAN; POLYMORPHONUCLEAR CELL; POLYOMA VIRUS; REVIEW; VIRION; VIRUS ADSORPTION; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS TRANSFORMATION; VIRUS VIRULENCE;

BK VIRUS; HUMANS; JC VIRUS; KIDNEY DISEASES; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; NEOPLASMS; POLYOMAVIRUS;

BK POLYOMAVIRUS; JC POLYOMAVIRUS; POLYOMAVIRUS;

EID: 33646693646     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5454-z     Document Type: Review

References (160)

1. Padgett B. L. and Walker D. L. (1976) New human papovaviruses. Prog. Med. Virol. 22: 1-35
2. Shah K. V. (1996) Polyomaviruses. In: Fields Virology, vol. 2, pp. 2027-2043, Fields B. N., Knipe D. M. and Howley P. M. (eds.), Lippincott-Raven, Philadelphia
3. Knowles W. A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D. W., et al. (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71: 115-123
4. Shinohara T., Matsuda M., Cheng S. H., Marshall J., Fujita M. and Nagashima K. (1993) BK virus infection of the human urinary tract. J. Med. Virol. 41: 301-305
5. Dorries K. and Elsner C. (1991) Persistent polyomavirus infection in kidney tissue of patients with disease other than progressive multifocal leukoencephalopathy. Virol. Adv. 10: 51-61
6. Chesters P. M., Heritage J. and McCance D. J. (1983) Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147: 676-84
7. Gardner S. D., Mackenzie E. F. D., Smith C. and Porter A. C. (1984) Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J. Clin. Pathol. 37: 578-586
8. Hogan T. F., Borden E. C., McBain J. A., Padgett B. L. and Walker D. L. (1980) Human polyomavirus infections with JC virus and BK in renal transplant patients. Ann. Intern. Med. 92: 373-378
9. Silverman L. and Rubinstein L. (1965) Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathol. (Berl) 5: 215-224
10. Aksamit A. J., Mourrain P., Sever J. L. and Major E. O. (1985) Progressive multifocal leukoencephalopathy: investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann. Neurol. 18: 490-496
11. Dorries K. (1998) Molecular biology and pathogenesis of human polyomavirus infections. Dev. Biol. Stand. 94: 71-79
12. Kahan A. V., Coleman D. V. and Koss L. G. (1980) Activation of human polyomavirus infection-detection by cytologic techniques. Am. J. Clin. Pathol. 74: 326-332
13. Coleman D. V., Wolfendale M. R., Daniel R. A., Dhanjal N. K., Gardner S. D., Gibson P. E. et al. (1980) A prospective study of human polyomavirus infection in pregnancy. J. Infect. Dis. 142: 1-8
14. Coleman D. V., Gardner S. D., Mulholland C., Fridiksdottir V., Porter A. A., Lilford R. et al. (1983) Human polyomavirus in pregnancy. A model for the study of defense mechanisms to virus reactivation. Clin. Exp. Immunol. 53: 289-296
15. Gibson P. E., Field A. M., Gardner S. D. and Coleman D. V. (1981) Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy. J. Clin. Pathol. 34: 674-679
16. Shah K. V., Daniel R., Madden D. and Stagno S. (1980) Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect. Immun. 30: 29-35
17. Mantyjarvi R., Meumiam O., Vihma L. and Berglund B. (1973) Human papovavirus (B. K.), biological properties and seroepidemiology. Ann. Dis. Res. 5: 283-287
18. Dubois V., Lafon M. E., Ragnaud J. M., Pellegrin J. L., Damasio F., Baudouin C. et al. (1996) Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS 10: 353-358
19. Dubois V., Dutronc H., Lafon M. E., Poinsot V., Pellegrin J. L., Ragnaud J. M. et al. (1997) Latency and reactivation of JC Virus in peripheral blood of human immunodeficiency virus type-1 infected patients. J. Clin. Micro. 35: 2288-2292
20. Dubois V., Moret H., Lafon M. E., Janvresse C. B., Dussaix E., Icart J. et al. (1998) Prevalence of JC virus viremia in HIV-infected patients with or without neurological disorders: a prospective study. J. Neurovirol. 4: 539-544
21. Lafon M. E., Dutronc H., Dubois V., Pellegrin I., Barbeau P., Ragnaud J. M. et al. (1998) JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. J. Infect. Dis. 177: 1502-1505
22. Arthur R. R., Shah K. V., Charache P. and Saral R. (1988) BK and JC virus infections in recipients of bone marrow transplants. J. Infect. Dis. 158: 563-569
23. Flower A. J., Banatvala J. E. and Chrystie I. L. (1977) BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease and healthy people. Br. Med. J. 2: 220-223
24. Markowitz R. B., Thompson H. C., Mueller J. F., Cohen J. A. and Dynan W. S. (1993) Incidence of BK Virus and JC Virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J. Infect. Dis. 167: 13-20
25. Sundsfjord A., Flaegstad T., Flo R., Spein A. R., Pedersen M. and Permin H. (1994) BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia and regulatory regions. J. Infect. Dis. 169: 485-490
26. Nickeleit V., Hirsch H. H., Binet I. F., Gudat F., Prince O. and Dalquen P. (1999) Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J. Am. Soc. Nephrol. 10: 1080-1089
27. Nickeleit V., Steiger J. and Mihatsch M. J. (2002) BK virus infection after kidney transplantation. Graft 5: S46-S57
28. Astrom K., Mancall E. and Richardson E. P. Jr (1958) Progressive multifocal leukoencephalopathy. Brain 81: 93-127
29. Richardson E. P. and Webster H. D. (1983) Progressive multifocal leukoencephalopathy: its pathological features. Prog. Clin. Biol. Res. 105: 191-203
30. Zu Rhein G. M. and Chou S. M. (1965) Particles resembling papovaviruses in human cerebral demyelinating disease. Science 148: 1477-1479
31. Zu Rhein G. M. (1967) Polyoma-like virions in a human demyelinating disease. Acta Neuropathol. (Berl) 8: 57-68
32. Gardner S. D., Field A. M., Coleman D. V. and Hulme B. (1971) New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1: 1253-1257
33. Padgett B., Zu Rhein G., Walker D., Echroade R. and Dessel B. (1971) Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1: 1257-1260
34. Padgett B. L., Rogers C. M. and Walker D. L. (1977) JC Virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships. Infect. Immun. 15: 656-662
35. Cole C. and Conzen S. D. (2001) Polyomaviridae: the viruses and their replication. In: Fundamental Virology, vol. 1, pp. 985-1018, Knipe D. M. and Howley P. M. (eds.), Lippincott Williams and Wilkins, Philadelphia
36. Moens U. and Rekvig P. (2001) Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection. In: Human Polyomaviruses: Molecular And Clinical perspectives, vol. 1, pp. 359-408, Khalili K. and Stoner G. L. (eds.), Wiley-Liss, New York
37. Miyamura T., Jikuya H., Soeda E. and Yoshiike K. (1983) Genomic structure of human polyoma virus JC: nucleotide sequence of the region containing replication origin and small-T-antigen gene. J. Virol. 45: 73-79
38. Dhar R., Lai C. J. and Khoury G. (1978) Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell 13: 345-358
39. Cubitt C. and Stoner G. L. (2002) Molecular genetics of the BK virus. Graft 5: S28-S35
40. Howley P. M. (1980) Molecular Biology of SV40 and the human polyomaviruses BK and JC. In: Viral Oncology, vol. pp. 489-550, Klein G. (eds.), Raven Press, New York
41. Howley P. M., Khoury G., Byrne J., Takemoto K. K. and Martin M. (1975) Physical map of the BK virus genome. J. Virol. 16: 959-973
42. Lee W. and Langhoff E. (2002) Polyomavirus and human cancer. Graft 5: S73-S81
43. Stubdal H., Zalvide J., Campbell K. S., Schweitzer C., Roberts T. M. and DeCaprio J. A. (1997) Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17: 4979-4990
44. Harris K. F., Chang E., Christensen J. B. and Imperiale M. J. (1998) BK virus as a potential co-factor in human cancer. Dev. Biol. Stand. 94: 81-91.
45. Harris K. F., Christensen J. B., Radany E. and Imperiale M. J. (1998) Novel mechanisms of E2F induction by BK virus large T antigen: requirement of both the pRb binding and J domains. Mol. Cell. Biol. 18: 1746-1756
46. Cassil J., Deyerle K. and Subranami S. (1989) Unidirectional deletion and linker scan analysis of the late promoter of the human polyomavirus BK. Virology 169: 172-181
47. Kamen R., Favaloro J. and Parker J. (1980) Topography of the three late mRNAs of the polyomavirus which encode the virion proteins. J. Virol. 33: 637-651
48. Liddington R., Yan Y., Moulai J., Sahli R., Benjamin T. and Harrison S. (1991) Structure of simian virus 40 at 3.8 A resolution. Nature 354: 278-284
49. Stehle T., Yan Y., Benjamin T. L. and Harrison S. C. (1994) Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369: 160-163
50. Stehle T. and Harrison S. C. (1997) High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 16: 5139-5148
51. Barouch D. and Harrison S. (1994) Interactions among the major and minor coat proteins of polyomavirus. J. Virol. 68: 3982-3989
52. Chen X. S., Stehle T. and Harrison S. C. (1998) Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J. 17: 3233-3240
53. Carswell S. and Alwine J. (1986) Simian virus agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J. Virol. 60: 1055-1061
54. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K. and Khalili K. (2001) Interaction of JC virus agnoprotein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 75: 1476-1486
55. Safak M., Sadowska B., Barrucco R. and Khalili K. (2002) Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 76: 3828-3838
56. Ahsan N. and Shah K. V. (2001) Polyomaviruses: an overview. Graft 5: S9-S18
57. Deyerle K., Cassil J. and Subranami S. (1987) Analysis of the early regulatory region of the human papovavirus BK. Virology 158: 181-193
58. Moens U. and Van Ghelue M. (2005) Polymorphism in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. Virology 331: 209-231
59. Kenney S., Natarajan V. Strike D., Khoury G. and Salzman N. (1984) JC virus enhancer-promoter active in human brain cells. Science 226: 1337-1339
60. Yoshiike K. and Takemoto K. K. (1986) Studies with BK virus and monkey lymphotropic papovavirus. In: The Papovaviridae, vol. 1, pp. 295-326, Salzman N. P. (eds.), Plenum Press, New York
61. Deyerle K., Sajjadi F. and Subranami S. (1989) Analysis of origin of DNA replication of human papovavirus BK. J. Virol. 62: 3378-3387
62. Dugan A., Eash S. and Atwood W. J. (2005) A N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor of BK virus. J. Virol. 79: 14442-14445
63. Liu C. K., Wei G. and Atwood W. J. (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha 2-6 linked sialic acids. J. Virol. 72: 4643-4649
64. Seganti L., Mastromarino P., Superti F., Sinibaldi L. and Orsi N. (1981) Receptors for BK virus on human erythrocytes. Acta Virol. 25: 177-181
65. Sinibaldi L., Viti D., Goldoni P., Cavallo G., Caroni C. and Orsi N. (1987) Inhibition of BK Virus Haemagglutination by Gangliosides. J. Gen. Virol. 68: 879-883
66. Sinibaldi L., Goldoni P., Pietropaolo V., Longhi C. and Orsi N. (1990) Involvement of gangliosides in the interaction between BK virus and Vero cells. Arch. Virol 113: 291-296
67. Elphick G., Querbes W., Jordan J., Gee G., Eash S., Manley K. et al. (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306: 1380-1383
68. Kasamatsu H. and Nakanishi A. (1998) How do animal DNA viruses get to the nucleus? Annu. Rev. Microbiol. 52: 627-686
69. Pho M. T., Ashok A. and Atwood W. J. (2000) JC Virus enters human glial cells by clathrin dependent receptor mediated endocytosis. J. Virol. 74: 2288-2292
70. Querbes W., Benmerah A., Tosoni D., Di Fiore P. P. and Atwood W. J. (2004) A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. J. Virol. 78: 250-256
71. Eash S., Querbes W. and Atwood W. J. (2004) Infection of Vero cells by BK virus is dependent on caveolae. J. Virol. 78: 11583-11590
72. Drachenberg R. C., Drachenberg C. B., Papadimitriou J. C., Ramos E., Fink J. C., Wali R. et al. (2001) Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am. J. Transplant. 1: 373-381.
73. Petrogiannis-Haliotis T., Sakoulas G., Kirby J., Koralnik I. J., Dvorak A. M., Monahan-Earley R. et al. (2001) BK-Related polyomavirus vasculopathy in a renal-transplant recipient. N. Engl. J. Med. 345: 1250-1255
74. Roth B. L., Berry S. A., Kroeze W. K., Willins D. L. and Kristiansen K. (1998) Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. Crit. Rev. Neurobiol. 12: 319-338
75. Dohner K. and Sodeik B. (2005) The role of the cytoskeleton during viral infection. Curr. Top. Microbiol. Immunol. 285: 67-108
76. Eash S. and Atwood W. J. (2005) Involvement of cytoskeletal components in BK virus infectious entry. J. Virol. 79: 11734-11741
77. Ashok A. and Atwood W. J. (2003) Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J. Virol. 77: 1347-1356.
78. Drachenberg C. B., Papadimitriou J. C., Wali R., Cubitt C. and Ramos E. (2003) BK Polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 3: 1383-1392
79. Nakanishi A., Clever J., Yamada M., Li P. P. and Kasamatsu H. (1996) Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. Proc. Natl. Acad. Sci. USA 93: 96-100
80. Feigenbaum L., Khalili K., Major E. and Khoury G. (1987) Regulation of the host range of human papovavirus JCV. Proc. Natl. Acad. Sci. USA 84: 3695-3698
81. Henson J. W. (1994) Regulation of the glial-specific JC virus early promoter by the transcription factor Sp 1. J. Biol. Chem 269: 1046-1050
82. Krebs C., McAvoy M. and Kumar G. (1995) The JC virus minimal core promoter is glial cell specific in vivo. J. Virol. 69: 2434-2442
83. Tada H., Lashgari M., Rappaport J. and Khalili K. (1989) Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J. Virol. 63: 463-466
84. Feigenbaum L., Hinrichs S. and Jay G. (1992) JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J. Virol. 66: 1176-1182
85. Lashgari M. S., Tada H., Amini S. and Khalili K. (1989) Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology 170: 292-295
86. Henson J., Saffer J. and Furneaux H. (1992) The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann. Neurol. 32: 72-77
87. Nakshatri H., Pater A. and Pater M. (1990) Activity and enhancer binding factors for JC virus regulatory elements in differentiating embryonal carcinoma cells. Virology 177: 784-789
88. Wegner M., Drolet D. W. and Rosenfeld M. G. (1993) Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90: 4743-4747
89. Chakraborty T. and Das G. (1991) Proteins of the nuclear factor-1 family act as an activator for the late promoter in human polyomavirus BK in vitro. J. Gen. Virol. 72: 1935-1942
90. Gorrill T. and Khalili K. (2005) Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter. Virology 335: 1-9
91. Kraus R. J., Shadley L. and Mertz J. E. (2001) Nuclear factor 1 family members mediate repression of the BK virus late promoter. Virology 287: 89-104.
92. Moens U., Sabramaniam N., Johansen B., Johansen T. and Traavik T. (1994) A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J. Virol. 68: 2398-2408
93. Moens U., Van Ghelue M., Johansen B. and Seternes O. M. (1999) Concerted expression of BK virus large T- and small t-antigens strongly enhances estrogen receptor-mediated transcription. J. Gen. Virol. 80: 585-594
94. Henson J., Schnitker B., Lee T. and McAllister J. (1995) Cell-specific activation of the glial-specific JC virus early promoter by large T antigen. J. Biol. Chem. 270: 13240-13245
95. Eki T., Enomoto T., Masutani C., Miyajima A., Takada R., Murakami Y. et al. (1991) Mouse DNA primase plays the principal role in determination of permissiveness for polyomavirus DNA replication. J. Virol. 65: 4874-4881
96. Murakami Y., Eki T., Yamada M., Prives C. and Hurwitz J. (1986) Species-specific in vitro synthesis of DNA containing the polyomavirus origin of replication. Proc. Natl. Acad. Sci. USA 83: 6347-6351
97. Schneider C., Weisshart K., Guarino L., Dornreiter I. and Fanning E. (1994) Species-specific functional interactions of DNA polymerase alpha-primase with simian virus 40 (SV40) T antigen require SV40 origin DNA. Mol. Cell. Biol. 14: 3176-3185
98. Sullivan C., Grundhoff A., Tevethia S., Pipas J. and Ganem D. (2005) SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686
99. Huang Y. L., Wang M., Ou W. C., Fung C. Y., Chen L. S. and Chang D. (2003) Analysis of DNA-binding activity of the JC virus minor capsid protein VP2. J. Neurovirol. 9: 21-24
100. Chang D., Fung C. Y., Ou W. C., Chao P. C., Li S. Y., Wang M. et al. (1997) Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J. Gen. Virol. 78: 1435-1439
101. Li T. C., Takeda N., Kato K., Nilsson J., Xing L., Haag L. et al. (2003) Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses. Virology 311: 115-124
102. Chen P. L., Wang M., Ou W C., Lii C. K., Chen L. S. and Chang D. (2001) Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions form chelation. FEBS Lett. 500: 109-113
103. Shishido-Hara Y., Hara Y., Larson T., Yasui K., Nagashima K. and Stoner G. L. (2000) Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1 and capsid assembly. J. Virol. 74: 1840-1853.
104. Ishii N., Nakanishi A., Yamada M., Macalalad M. H. and Kasamatsu H. (1994) Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins. J. Virol. 68: 8209-8216
105. Lin W., Hata T. and Kasamatsu H. (1984) Subcellular distribution of viral structural proteins during simian virus 40 infection. J. Virol. 50: 363-371
106. Clever J., Yamada M. and Kasamatsu H. (1991) Import of simian virus 40 virions through nuclear pore complexes. Proc. Natl. Acad. Sci. USA 88: 7333-7337
107. Forstova J., Krauzewicz N., Wallace S., Street A. J., Dilworth S., Beard S. et al. (1993) Cooperation of structural proteins during late events in the life cycle of polyomavirus. J. Virol. 67: 1405-1413
108. Shishido-Hara Y., Ichinose S., Higuchi K., Hara Y. and Yasui K. (2004) Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J. Virol. 78: 9890-9903
109. Tang Q., Bell P., Tegtmeyer P. and Maul G. (2000) Replication but not transcription of simian virus 40 DNA dependent on nuclear domain 10. J. Virol. 74: 9694-9700
110. Imperiale M. J. (2001) Human polyomaviruses: molecular and clinical perspectives. In: The Human Polyomaviruses: An Overview, vol. pp. 53-71, Khalili K. and Stoner G. L. (eds.), Wiley-Liss, New York
111. Clayson E. T., Brando L. V. and Compans R. W. (1989) Release of simian virus 40 from epithelial cells is polarized and occurs without lysis. J. Virol. 63: 2278-2288
112. Trofe J., Gordon J., Roy-Chaudhury P., Koralnik I. J., Atwood W. J., Eash S. et al. (2004) Basic and clinical research in polyomavirus nephropathy. Exp. Clin. Transpl. 2: 162-173
113. Berger J. R. and Concha M. (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1: 5-18
114. Ahuja M., Cohen E. P. and Dayer A. M. (2001) Polyomavirus infection after renal transplantation: use of immunostaining as a guide to diagnosis. Transplantation 68: 1279-1288
115. Randhawa P. S. and Demetris A. J. (2000) Nephropathy due to polyomavirus type BK. N. Engl. J. Med. 342: 1309-1315
116. Nickeleit V., Hirsch H. H., Zeiler M., Prince O., Thiel G. and Mihatsch M. J. (2000) BK-virus nephropathy in renal transplants - tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol. Dial. Transplant. 15: 324-332
117. Kazory A. and Ducloux D. (2004) Polyomaviruses and transplant patients: new concepts. Transpl. Infect. Dis 6: 136-137
118. Trofe J., Gordon J., Roy-Chaudhury P., Koralnik I. J., Atwood W. J., Alloway R. R. et al. (2004) Polyomavirus nephropathy in kidney transplantation. Prog. Transplant. 14: 130-140
119. Scantlebury V., Shapiro R., Randhawa P., Weck K. and Vats A. (2002) Cidofofir: a method of treatment for BK virus-associated transplant nephropathy. Graft 5: S82-S87
120. Reploeg M., Storch G. and Clifford D. (2001) BK virus: a clinical review. Clin. Infect. Dis. 33: 191-202
121. Fishman J. A. (2002) BK virus nephropathy - polyomavirus adding insult to injury. N. Engl. J. Med. 347: 527-530
122. Cavanagh J. and Lond M. (1959) Cerebral demyelination associated with disorders of the reticuloendothelial system. Lancet 33: 524-529
123. Richardson E. P. Jr (1961) Progressive multifocal leukoencephalopathy. N. Engl. J. Med. 265: 815-823
124. Richardson E. P. and Johnson P. C. (1975) Atypical progressive multifocal leukoencephalopathy with plasma cell infiltrates. Acta. Neuropathol. Suppl. 6: 247-250
125. Weber F., Goldmann C., Kramer M., Kaup F. J., Pickhardt M., Young P., et al. (2001) Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann. Neurol. 49: 636-642
126. Major E. O. and Ault G. S. (1995) Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr. Opin. Neurol. 8: 184-190
127. Chowdhury M., Taylor J. P., Tada H., Rappaport J., Wong-Staal F., Amini S. et al. (1990) Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 5: 1737-1742
128. Chowdhury M., Taylor J. P., Chang C. F., Rappaport J. and Khalili K. (1992) Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J. Virol. 66: 7355-7361
129. Chowdhury M., Kundu M. and Khalili K. (1993) GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 8: 887-892
130. Cullen B. (1990) The HIV-1 Tat protein: an RNA sequence-specific processivity factor? Cell 63: 655-657
131. Lecatsas G., Schoub B. D., Rabson A. R. and M. J. (1976) Papovavirus in human lymphocyte cultures. Lancet 2: 907-908
132. Koralnik I. J., Schmitz J. E., Lifton M. A., Forman M. A. and Letvin N. L. (1999) Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J. Neurovirol. 5: 430-435.
133. Atwood W. J., Amemiya K., Traub R., Harms J. and Major E. O. (1992) Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190: 716-723
134. Monaco M. G. C., Atwood W. J., Gravell M., Tornatore C. S. and Major E. O. (1996) JCV infection of hematopoetic progenitor cells, primary B lymphocytes and tonsillar stromal cells: implication for viral latency. J. Virol. 70: 7004-7012
135. Monaco M. C., Shin J. and Major E. O. (1998) JC virus infection in cells from lymphoid tissue. Dev. Biol. Stand. 94: 115-122
136. Monaco M. C., Jensen P. N., Hou J., Durham L. C. and Major E. O. (1998) Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 72: 9918-9923
137. Houff S. A., Major E. O., Katz D. A., Kufta C. V., Sever J. L., Pittaluga S. et al. (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N. Engl. J. Med. 318: 301-305
138. Tornatore C., Berger J. R., Houff S. A., Curfman B., Meyers K., Winfield D. et al. (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann. Neurol. 31: 454-462
139. Sabath B. F. and Major E. O. (2002) Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J. Infect. Dis. 186: S180-S186
140. Fong I. W and Toma E. (1995) The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML study group. Clin. Infect. Dis. 20: 1305-1310
141. Kuchelmeister K., Gullota F., Bergmann M., Angeli G. and Masini T. (1993) Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol. Res. Pract. 189: 163-173
142. Hou J. and Major E. O. (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J. Neurovirol. 4: 451-456.
143. Power C., Nath A., Aoki F. Y. and Del Bigio M. (1997) Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N. Engl. J. Med. 336: 661-662
144. Kent S. J., Karlik S. J., Cannon C., Hines D. K., Yednock T. A., Fritz L. C. et al. (1995) A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J. Neuroimmunol. 58: 1-10
145. Berger J. R. and Koralnik I. J. (2005) Progressive multifocal leukoencephalopathy and natalizumab - unforeseen consequences. N. Engl. J. Med. 353: 414-416
146. Mathur V., Olson J., Darragh T. and Yen T. (1997) Polyomavirus-induce interstitial nephritis in two renal transplant recipients: case reports and review of literature. Am. J. Kidney Dis. 29: 754-758
147. Krynska B., Gordon J., Otte J., Franks R., Knobler R., DeLuca A. et al. (1997) Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J. Cell. Biochem. 67: 223-230
148. Staib C., Pesch J., Gerwig R., Gerber J., Brehm U., Stangl A. et al. (1996) p53 inhibits JC virus DNA in vivo and interacts with JC virus large T-Ag. Virology 219: 237-246
149. Fioriti D., Videtta M., Mischitelli M., Degener A. M., Russo G., Giordano A. et al. (2005) Human polyomavirus BK: potential role in cancer. J. Cell. Physiol. 204: 402-406
150. Imperiale M. J. (2000) The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 267: 1-7
151. White M. K. and Khalili K. (2004) Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324: 1-6
152. Pagnani M., Corallini A., Caputo A., Altavilla G., Selvatici R., Catozzi L. et al. (1988) Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene. Int. J. Cancer 42: 405-413
153. Tognon M., Corallini A., Martini F., Negrini M. and Barbanti-Brodano G. (2003) Oncogenic transformation by BK virus and association with human tumors. Oncogene 22: 5192-5200
154. Rollison D. E., Utaipat U., Ryschkewitsch C., Hou J., Goldthwaite P., Daniel R. et al. (2005) Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int. J. Cancer 113: 769-774
155. Arthur R. R., Grossman S. A., Ronnett B. M., Bigner S. H., Vogelstein B. and Shah K. V. (1994) Lack of association of human polyomaviruses with human brain tumors. J. Neurooncol. 20: 55-58
156. Casini B., Borgese L., Del Nonno F., Galati G., Izzo L., Caputo M. et al. (2005) Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer Res. 25: 1079-1085
157. Gellrich S., Schewe C., Sterry W. and Lukowsky A. (2005) Absence of SV40 and other polyomavirus (JCV, BKV) DNA in primary cutaneous B cell lymphomas. J. Invest. Dermatol. 124: 278-279
158. Delbue S., Pagani E., Guerini F. R., Agliardi C., Mancuso R., Borghi E. et al. (2005) Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J. Med. Virol. 77: 447-454
159. Del Valle L., White M. K., Enam S., Oviedo S. P., Bromer M. Q., Thomas R. M. et al. (2005) Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 103: 516-527
160. Enam S., Del Valle L., Lara C., Gan D. D., Ortiz-Hidalgo C., Palazzo J. P. et al. (2002) Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res. 62: 7093-7101